Plasma Fractionation Market: Global Industry Growth, Trends, Opportunities, and Forecast

The Plasma Fractionation Market is witnessing steady expansion as demand grows for plasma-derived therapies used in the treatment of immune deficiencies, bleeding disorders, neurological conditions, and other chronic diseases. According to Market Research Future, the market was valued at USD 31.82 billion in 2024 and is projected to reach USD 64.22 billion by 2035, registering a CAGR of approximately 6.59% during 2025–2035.

Increasing demand for immunoglobulins, albumin, and coagulation factors is a major factor supporting market growth. Plasma fractionation separates donated plasma into valuable proteins that can be developed into therapeutic products for patients with rare and chronic conditions. Growing awareness of plasma-derived medicines and improvements in healthcare infrastructure are further supporting adoption.

Technological advancements in centrifugation, chromatography, precipitation, and filtration are improving processing efficiency and product recovery. The immunoglobulin segment represents a major portion of the market, supported by growing demand for therapies addressing immune and autoimmune disorders.

North America currently leads the global market, while Asia-Pacific is expected to provide attractive future opportunities as healthcare infrastructure, plasma collection capabilities, and awareness of plasma-derived therapies expand.

Overall, rising disease prevalence, technological innovation, increasing plasma collection, and growing demand for specialized therapies are expected to drive continued development of the global plasma fractionation industry.